
Phase 2a Prader-Willi Syndrome Trial Enters Open-Label Extension
According to a story from finanznachrichten.de, the biotechnology company Saniona recently announced that its treatment period for adolescent patients in its Phase 2a clinical trial testing Tesomet as a treatment for…